A16A1_HUMAN - dbPTM
A16A1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID A16A1_HUMAN
UniProt AC Q8IZ83
Protein Name Aldehyde dehydrogenase family 16 member A1
Gene Name ALDH16A1
Organism Homo sapiens (Human).
Sequence Length 802
Subcellular Localization
Protein Description
Protein Sequence MAATRAGPRAREIFTSLEYGPVPESHACALAWLDTQDRCLGHYVNGKWLKPEHRNSVPCQDPITGENLASCLQAQAEDVAAAVEAARMAFKGWSAHPGVVRAQHLTRLAEVIQKHQRLLWTLESLVTGRAVREVRDGDVQLAQQLLHYHAIQASTQEEALAGWEPMGVIGLILPPTFSFLEMMWRICPALAVGCTVVALVPPASPAPLLLAQLAGELGPFPGILNVLSGPASLVPILASQPGIRKVAFCGAPEEGRALRRSLAGECAELGLALGTESLLLLTDTADVDSAVEGVVDAAWSDRGPGGLRLLIQESVWDEAMRRLQERMGRLRSGRGLDGAVDMGARGAAACDLVQRFVREAQSQGAQVFQAGDVPSERPFYPPTLVSNLPPASPCAQVEVPWPVVVASPFRTAKEALLVANGTPRGGSASVWSERLGQALELGYGLQVGTVWINAHGLRDPSVPTGGCKESGCSWHGGPDGLYEYLRPSGTPARLSCLSKNLNYDTFGLAVPSTLPAGPEIGPSPAPPYGLFVGGRFQAPGARSSRPIRDSSGNLHGYVAEGGAKDIRGAVEAAHQAFPGWAGQSPGARAALLWALAAALERRKSTLASRLERQGAELKAAEAEVELSARRLRAWGARVQAQGHTLQVAGLRGPVLRLREPLGVLAVVCPDEWPLLAFVSLLAPALAYGNTVVMVPSAACPLLALEVCQDMATVFPAGLANVVTGDRDHLTRCLALHQDVQAMWYFGSAQGSQFVEWASAGNLKPVWASRGCPRAWDQEAEGAGPELGLRVARTKALWLPMGD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Methylation---MAATRAGPRARE
---CCCCCCCHHHHH
32.59-
15PhosphorylationPRAREIFTSLEYGPV
HHHHHHHHCCCCCCC
37.7624719451
16PhosphorylationRAREIFTSLEYGPVP
HHHHHHHCCCCCCCC
14.4128348404
19PhosphorylationEIFTSLEYGPVPESH
HHHHCCCCCCCCHHH
31.8330804103
25PhosphorylationEYGPVPESHACALAW
CCCCCCHHHHEEEHH
15.4346161905
47UbiquitinationLGHYVNGKWLKPEHR
HHHHHCCEECCHHHC
44.12-
50AcetylationYVNGKWLKPEHRNSV
HHCCEECCHHHCCCC
47.4419608861
50UbiquitinationYVNGKWLKPEHRNSV
HHCCEECCHHHCCCC
47.4419608861
62UbiquitinationNSVPCQDPITGENLA
CCCCCCCCCCCCHHH
10.5221890473
85UbiquitinationDVAAAVEAARMAFKG
HHHHHHHHHHHHHCC
8.1827667366
91 (in isoform 2)Ubiquitination-50.3521890473
91UbiquitinationEAARMAFKGWSAHPG
HHHHHHHCCCCCCCC
50.3521890473
91 (in isoform 1)Ubiquitination-50.3521890473
91UbiquitinationEAARMAFKGWSAHPG
HHHHHHHCCCCCCCC
50.3521890473
114AcetylationRLAEVIQKHQRLLWT
HHHHHHHHHHHHHHH
30.4926822725
114UbiquitinationRLAEVIQKHQRLLWT
HHHHHHHHHHHHHHH
30.4933845483
121PhosphorylationKHQRLLWTLESLVTG
HHHHHHHHHHHHHHC
22.1819413330
124PhosphorylationRLLWTLESLVTGRAV
HHHHHHHHHHHCCCH
31.1172550343
127PhosphorylationWTLESLVTGRAVREV
HHHHHHHHCCCHHHH
26.6624719451
216UbiquitinationLLAQLAGELGPFPGI
HHHHHHHHHCCCCCH
44.9722505724
245UbiquitinationASQPGIRKVAFCGAP
HCCCCCCEEEECCCC
35.6729901268
275PhosphorylationELGLALGTESLLLLT
HHHHHHCCCEEEEEE
24.2123401153
277PhosphorylationGLALGTESLLLLTDT
HHHHCCCEEEEEECC
24.9323401153
282PhosphorylationTESLLLLTDTADVDS
CCEEEEEECCCCHHH
31.1323401153
284PhosphorylationSLLLLTDTADVDSAV
EEEEEECCCCHHHHH
21.3723401153
289PhosphorylationTDTADVDSAVEGVVD
ECCCCHHHHHHCHHH
33.7823401153
332PhosphorylationERMGRLRSGRGLDGA
HHHCHHHCCCCCCCC
37.1228270605
342SulfoxidationGLDGAVDMGARGAAA
CCCCCCCCCHHHHHH
3.4830846556
362UbiquitinationRFVREAQSQGAQVFQ
HHHHHHHHCCCEEEE
37.3121890473
362UbiquitinationRFVREAQSQGAQVFQ
HHHHHHHHCCCEEEE
37.3121963094
375PhosphorylationFQAGDVPSERPFYPP
EECCCCCCCCCCCCC
46.1930631047
384UbiquitinationRPFYPPTLVSNLPPA
CCCCCCCHHCCCCCC
4.9821963094
413 (in isoform 1)Ubiquitination-42.7921890473
413UbiquitinationASPFRTAKEALLVAN
ECCCCCHHHHHHEEC
42.7921963094
422PhosphorylationALLVANGTPRGGSAS
HHHEECCCCCCCCHH
15.0426714015
424MethylationLVANGTPRGGSASVW
HEECCCCCCCCHHHH
63.04-
448UbiquitinationLGYGLQVGTVWINAH
HCCCCEEECEEEECC
11.1121963094
468UbiquitinationSVPTGGCKESGCSWH
CCCCCCCCCCCCCCC
59.18-
470UbiquitinationPTGGCKESGCSWHGG
CCCCCCCCCCCCCCC
30.5121963094
482PhosphorylationHGGPDGLYEYLRPSG
CCCCCCHHHHHCCCC
14.2022817900
488O-linked_GlycosylationLYEYLRPSGTPARLS
HHHHHCCCCCCHHHH
49.1929351928
488PhosphorylationLYEYLRPSGTPARLS
HHHHHCCCCCCHHHH
49.1925627689
490PhosphorylationEYLRPSGTPARLSCL
HHHCCCCCCHHHHHH
20.3625627689
499UbiquitinationARLSCLSKNLNYDTF
HHHHHHHCCCCCCCC
53.1321963094
513UbiquitinationFGLAVPSTLPAGPEI
CCEECCCCCCCCCCC
30.5921890473
513UbiquitinationFGLAVPSTLPAGPEI
CCEECCCCCCCCCCC
30.5921890473
535MethylationYGLFVGGRFQAPGAR
CCEEECCEECCCCCC
17.99-
535UbiquitinationYGLFVGGRFQAPGAR
CCEEECCEECCCCCC
17.9921890473
543PhosphorylationFQAPGARSSRPIRDS
ECCCCCCCCCCCCCC
30.1126657352
544PhosphorylationQAPGARSSRPIRDSS
CCCCCCCCCCCCCCC
36.2026657352
550PhosphorylationSSRPIRDSSGNLHGY
CCCCCCCCCCCEEEE
30.2326657352
551PhosphorylationSRPIRDSSGNLHGYV
CCCCCCCCCCEEEEE
35.6728270605
557PhosphorylationSSGNLHGYVAEGGAK
CCCCEEEEEECCCCC
5.9223312004
564UbiquitinationYVAEGGAKDIRGAVE
EEECCCCCCHHHHHH
57.8921963094
564 (in isoform 1)Ubiquitination-57.8921890473
567MethylationEGGAKDIRGAVEAAH
CCCCCCHHHHHHHHH
36.83-
567UbiquitinationEGGAKDIRGAVEAAH
CCCCCCHHHHHHHHH
36.8322817900
584PhosphorylationFPGWAGQSPGARAAL
CCCCCCCCHHHHHHH
25.12110754377
589UbiquitinationGQSPGARAALLWALA
CCCHHHHHHHHHHHH
11.2622817900
618AcetylationERQGAELKAAEAEVE
HHCCCHHHHHHHHHH
36.7420167786
618 (in isoform 1)Ubiquitination-36.7421890473
618UbiquitinationERQGAELKAAEAEVE
HHCCCHHHHHHHHHH
36.7422817900
743UbiquitinationHQDVQAMWYFGSAQG
CHHHHHHHHHCCCCC
6.5822505724
751O-linked_GlycosylationYFGSAQGSQFVEWAS
HHCCCCCHHHHHHHH
14.36OGP
765UbiquitinationSAGNLKPVWASRGCP
HCCCCCCEEHHCCCC
6.7922505724
794UbiquitinationGLRVARTKALWLPMG
HHHHEEEEEEEEECC
35.6122505724

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of A16A1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of A16A1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of A16A1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
DEOC_HUMANDERAphysical
22863883
FUBP2_HUMANKHSRPphysical
22863883
MEA1_HUMANMEA1physical
22863883
PURB_HUMANPURBphysical
22863883

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of A16A1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-50, AND MASS SPECTROMETRY.

TOP